M&A · Healthcare · Buyer's industry: Pharmaceutical Preparations
BioMarin Pharmaceutical Inc to acquire Alesta Therapeutics
Announced Aug 18, 2026 · Closed Aug 31, 2026 · Private target
Deal value—
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationNot disclosed
Transaction
- Acquirer
- BioMarin Pharmaceutical Inc (BMRN)
- Target
- Alesta Therapeutics
- Buyer type
- Strategic
- Offer price per share
- —
- Enterprise value
- —
- Status
- Closed Aug 31, 2026
Deal protections
Not disclosed for private-company acquisitions.
Advisors
- To the acquirer
- Morgan Stanley
- To the target
- JPMorgan
Classification
- Sector
- Healthcare
- Buyer's industry
- Pharmaceutical Preparations